Trials / Active Not Recruiting
Active Not RecruitingNCT06878170
A First in Human Study to Evaluate the Safety and Immunogenicity of RBM-001 in Healthy Adult Volunteers
- Status
- Active Not Recruiting
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Rock BioMedical, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
A First in Human Study to Evaluate the Safety and Immunogenicity of RBM-001 in Healthy Adult Volunteers
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | RBM-001 | To evaluate the safety and tolerability of the RBM-001 vaccination in healthy adults. |
Timeline
- Start date
- 2024-09-30
- Primary completion
- 2025-05-30
- Completion
- 2026-01-30
- First posted
- 2025-03-14
- Last updated
- 2025-08-08
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT06878170. Inclusion in this directory is not an endorsement.